Neoadjuvant chemo-immunotherapy following concurrent immuno-chemoradiotherapy and immune-maintenance therapy as primary treatment for locally advanced cervical cancer: A prospective, single-arm, phase 2 trial.Fo-Ping Chen, Weijun Ye, Hai-Ying Wu et al.|Journal of Clinical Oncology|2024Cited by 1
Establishment of a Novel Risk Stratification System Integrating Clinical and Pathological Parameters for Prognostication and Clinical Decision‐Making in Early‐Stage Cervical CancerHai-Ying Wu, Xinping Cao, Lin Huang et al.|Cancer Medicine|2024Cited by 0